Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Levi

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
American Journal of Physiology. Renal Physiology|September 29, 2025
The nonsteroidal MR antagonist finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammationKomuraiah Myakala, Xiaoxin X Wang, Nataliia Shults, et al.
The American Journal of Pathology|February 15, 2025
Multimodal Diagnostic Imaging of Metabolic Dysfunction-Associated Steatotic Liver Disease: Noninvasive Analyses by Photoacoustic Ultrasound and Magnetic Resonance ImagingAlissa Keegan, Gayathri Malamal, Yichien Lee, et al.
American Journal of Physiology. Renal Physiology|July 4, 2024
NAD deficiency contributes to progressive kidney disease in HIV-nephropathy miceTeruhiko Yoshida, Komuraiah Myakala, Bryce A Jones, et al.
Iscience|March 21, 2022
Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liverTatsuya Yamada, Daisuke Murata, David E Kleiner, et al.
ACS Bio & Med Chem Au|July 25, 2022
Discovery of JND003 as a New Selective Estrogen-Related Receptor α Agonist Alleviating Nonalcoholic Fatty Liver Disease and Insulin ResistanceLiufeng Mao, Lijie Peng, Xiaomei Ren, et al.
Journal of the American Society of Nephrology : JASN|October 2, 2015
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and DiabetesXiaoxin X Wang, Michal Herman Edelstein, Uzi Gafter, et al.
American Journal of Physiology. Renal Physiology|June 5, 2009
Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiencySophia Y Breusegem, Hideaki Takahashi, Hector Giral-Arnal, et al.
The Journal of Biological Chemistry|February 16, 2017
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICEXiaoxin X Wang, Jonathan Levi, Yuhuan Luo, et al.
Circulation|April 20, 2011
Triglycerides and cardiovascular disease: a scientific statement from the American Heart AssociationMichael Miller, Neil J Stone, Christie Ballantyne, et al.
American Journal of Physiology. Cell Physiology|April 11, 2024
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic miceBlythe D Shepard, Jennifer Chau, Ryan Kurtz, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
American Journal of Physiology. Renal Physiology|September 29, 2025
The nonsteroidal MR antagonist finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammationKomuraiah Myakala, Xiaoxin X Wang, Nataliia Shults, et al.
The American Journal of Pathology|February 15, 2025
Multimodal Diagnostic Imaging of Metabolic Dysfunction-Associated Steatotic Liver Disease: Noninvasive Analyses by Photoacoustic Ultrasound and Magnetic Resonance ImagingAlissa Keegan, Gayathri Malamal, Yichien Lee, et al.
American Journal of Physiology. Renal Physiology|July 4, 2024
NAD deficiency contributes to progressive kidney disease in HIV-nephropathy miceTeruhiko Yoshida, Komuraiah Myakala, Bryce A Jones, et al.
Iscience|March 21, 2022
Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liverTatsuya Yamada, Daisuke Murata, David E Kleiner, et al.
ACS Bio & Med Chem Au|July 25, 2022
Discovery of JND003 as a New Selective Estrogen-Related Receptor α Agonist Alleviating Nonalcoholic Fatty Liver Disease and Insulin ResistanceLiufeng Mao, Lijie Peng, Xiaomei Ren, et al.
Journal of the American Society of Nephrology : JASN|October 2, 2015
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and DiabetesXiaoxin X Wang, Michal Herman Edelstein, Uzi Gafter, et al.
American Journal of Physiology. Renal Physiology|June 5, 2009
Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiencySophia Y Breusegem, Hideaki Takahashi, Hector Giral-Arnal, et al.
The Journal of Biological Chemistry|February 16, 2017
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICEXiaoxin X Wang, Jonathan Levi, Yuhuan Luo, et al.
Circulation|April 20, 2011
Triglycerides and cardiovascular disease: a scientific statement from the American Heart AssociationMichael Miller, Neil J Stone, Christie Ballantyne, et al.
American Journal of Physiology. Cell Physiology|April 11, 2024
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic miceBlythe D Shepard, Jennifer Chau, Ryan Kurtz, et al.
Pageof 20